Ariz. Admin. Code § R9-7-905 - Medical Particle Accelerator Equipment, Facility and Shielding, and Spot Checks
A.
Equipment
1. Leakage radiation
a. X-ray leakage radiation from the source
housing assembly shall not exceed 0.1 percent of the maximum dose equivalent
rate of the unattenuated useful beam.
b. Neutron leakage radiation from the source
housing assembly shall not exceed 0.5 percent of the maximum dose equivalent
rate of the unattenuated useful beam.
c. Leakage radiation measurements made at any
point 1 meter from the path of the charged particle between its point of origin
and the target, window or scattering foil shall meet the requirements of
subsection (A)(1)(a) and (b) when computed as a percentage of the dose rate
equivalent of the unattenuated useful beam measured at 1 meter from the virtual
source. Leakage radiation measurements at each point shall be averaged over an
area up to but not exceeding 100 square centimeters (15.5 square
inches).
d. The registrant shall
maintain, for inspection by the Department, records that show leakage radiation
measurements for the life of the operation.
2. Beam limiting devices (not to include
blocks or wedges). Adjustable or interchangeable beam limiting devices shall be
provided and shall transmit no more than 2 percent of the useful beam for the
portion of the useful beam that is to be attenuated by the beam limiting
device. The neutron component of the useful beam shall not be included in this
requirement. Measurements shall be averaged over an area up to but not
exceeding 100 square centimeters (15.5 square inches) at the normal treatment
distance.
3. Filters. The following
requirements apply to systems that use a system of wedge filters,
interchangeable field flattening filters, or interchangeable beam scattering
filters:
a. Irradiation shall not be possible
until a selection of a filter has been made at the treatment control
panel;
b. An interlock system shall
be provided to prevent irradiation if the filter selected is not in the correct
position;
c. An indication of the
wedge filter orientation with respect to the treatment field shall be provided
at the control panel, by direct observation, or by electronic means, when wedge
filters are used;
d. A display
shall be provided at the treatment control panel showing the filter or filters
in use;
e. Each filter that is
removable from the system shall be clearly identified as to that filter's
material of construction, thickness, and the nominal wedge angle for wedge
filters, or a record tracing these factors for each filter shall be maintained
at the system console; and
f. An
interlock shall be provided to prevent irradiation if any filter selection
operation carried out in the treatment room does not agree with the filter
selection operation carried out at the treatment control panel.
4. Beam monitor. Equipment
installed after the effective date of this Section shall be provided with at
least one radiation detector in the radiation head. This detector shall be
incorporated into a primary system so that all of the following criteria are
met:
a. Each primary system shall have a
detector that is a transmission detector and a full beam detector and that is
placed on the patient side of any fixed added filters other than a wedge
filter;
b. The detectors shall be
removable only with tools and shall be interlocked to prevent incorrect
positioning;
c. Each detector shall
be capable of independently monitoring and controlling the useful
beam;
d. Each detector shall form
part of a dose-monitoring system from which the absorbed dose can be calculated
at a reference point in the treatment volume;
e. Each dose monitoring system shall have a
legible display at the treatment control panel that:
i. Maintains a reading until intentionally
reset to zero;
ii. Has only one
scale and no scale multiplying factors in replacement equipment; and
iii. Utilizes a design such that increasing
dose is displayed by increasing numbers and is designed so that, in the event
of an overdosage of radiation, the absorbed dose may be accurately determined
under all nominal conditions of use or foreseeable failures;
f. In the event of power failure,
the dose monitoring information required in subsection (A)(4) displayed at the
control panel at the time of failure shall be retrievable in at least one
system; and
g. Selection and
display of dose monitor units;
i. Irradiation
shall not be possible until a selection of dose monitor units has been made at
the treatment control panel.
ii.
Each primary system shall terminate irradiation when the preselected number of
dose monitor units has been detected by the system.
iii. Each secondary system shall terminate
irradiation when 110 percent of the preselected number of dose monitor units
has been detected by the system.
iv. It shall be possible to interrupt
irradiation and equipment movements at any time from the operator's position at
the treatment control panel. Following an interruption, it shall be possible to
restart irradiation by operator action without any reselection of operating
conditions. If any change is made of a preselected value during an interruption
the equipment shall go to termination condition.
v. It shall be possible to terminate
irradiation and equipment movements, or go from an interruption condition to
termination conditions at any time from the operator's position at the
treatment control panel.
5. Beam monitoring system. All accelerator
systems shall be provided with a beam monitoring system in the radiation head
capable of monitoring and terminating irradiation.
a. Each beam monitoring system shall have a
display at the treatment control panel that registers the accumulated monitor
units.
b. The beam monitoring
system shall terminate irradiation if the preselected number of monitor units
has been detected by the system.
c.
For units with a secondary beam monitoring system, the primary beam monitoring
system shall terminate irradiation if the preselected number of monitor units
has been detected. The secondary beam monitoring system shall terminate
irradiation if the primary system fails.
d. In the event of a power failure, the
display information required in subsection (A)(5)(a) shall be retained in at
least one system following the power failure.
e. An interlock device shall prevent
irradiation if any beam monitoring system is inoperable.
f. For purposes of this rule:
i. "Beam monitoring system" means a system of
devices that will monitor the useful beam during irradiation and will terminate
irradiation if a preselected number of monitor units is accumulated.
ii. "Monitor unit" means a unit response from
the beam monitoring system from which the absorbed dose can be
calculated.
6. Treatment beam mode selection. In
equipment capable of both x-ray and electron therapy:
a. Irradiation shall not be possible until a
selection of radiation type is made at the treatment control panel;
b. An interlock system shall be provided to
prevent irradiation if any selected operations carried out in the treatment
room do not agree with the selected operations indicated at the treatment
control panel;
c. An interlock
system shall be available and in operating condition on a therapy machine, and
shall be used to prevent unwanted x-ray or electron irradiation when preparing
for, or performing radiation therapy procedures. The interlock system need not
be available for use, if the therapy machine is only used to make an image of
an inanimate object; and
d. The
radiation type selected shall be displayed at the treatment control panel
before and during irradiation.
7. Treatment beam energy selection. Equipment
capable of generating radiation beams of different energies shall meet all of
the following requirements:
a. Irradiation
shall not be possible until a selection of energy is made at the treatment
control panel;
b. An interlock
system shall be provided to ensure that the equipment can emit only the energy
of radiation that is selected;
c.
An interlock system shall be provided to prevent irradiation if any selected
operations carried out in the treatment room do not agree with the selected
operations indicated at the treatment control panel; and
d. The energy selected shall be displayed at
the treatment control panel before and during irradiation.
8. Selection of stationary or moving beam
therapy. Equipment capable of both stationary and moving beam therapy modes
shall meet all of the following requirements:
a. Irradiation shall not be possible until a
selection of stationary beam therapy or moving beam therapy is made at the
treatment control panel;
b. An
interlock system shall be provided to ensure that the equipment can operate
only in the mode that is selected;
c. An interlock system shall be provided to
prevent irradiation if any selected operations carried out in the treatment
room do not agree with the selected operations indicated at the treatment
control panel;
d. An interlock
system shall be provided to terminate irradiation if the movement stops during
moving beam therapy;
e. Moving beam
therapy shall be so controlled that the required relationship between the
number of dose monitor units and movement is obtained; and
f. The mode of operation shall be displayed
at the treatment control panel.
9. Focal spot location and beam orientation.
The registrant shall determine, or obtain from the manufacturer, the location
in reference to an accessible point on the radiation head of all of the
following:
a. The x-ray target or the virtual
source of x-rays,
b. The electron
window or the scattering foil, and
c. All possible orientations of the useful
beam.
10. System
checking facilities. Capabilities shall be provided for checking of all safety
interlock systems.
B.
Facility and shielding requirements.
1. In
addition to protective barriers sufficient to ensure compliance with R9-7-907,
all of the following design requirements apply:
a. Except for entrance doors or beam
interceptors, all the required barriers shall be fixed barriers;
b. The treatment control panel shall be
located outside the treatment room;
c. Windows, mirrors, operable closed-circuit
television, or other equivalent viewing systems shall be provided to permit
continuous observation of the patient during irradiation and shall be so
located that the operator may observe the patient from the treatment control
panel;
d. Provision shall be made
for two-way oral communication between the patient and the operator at the
treatment control panel;
e. Each
point of entry into the treatment room shall be provided with warning lights
that will indicate when the useful beam is "on" in a readily observable
position outside of the room; and
f. Interlocks shall be provided and shall
result in all entrance doors being closed before treatment can be initiated or
continued. If the radiation beam is interrupted by any door opening, it shall
be possible to restore the machine to operation only by closing the door and
reinitiating exposure by manual action at the control panel.
2. An authorized medical
physicist, trained and experienced in the principles of radiation protection,
shall perform a radiation protection survey on all installations before human
use and after any change in an installation that might produce a radiation
hazard. The authorized medical physicist shall provide the survey results in
writing to the individual in charge of the installation and transmit a copy of
the survey results to the Department.
3. Calibrations.
a. Calibration of the therapy system,
including radiation output calibration, shall be performed before placing new
installations into operation for the purpose of irradiation of patients.
Subsequent calibrations shall be made at intervals not to exceed 12 months, and
after any change that may cause the calibration of the therapy system to
change.
b. Calibration of the
radiation output of the therapy beam shall be performed with an instrument that
has been calibrated using a method that is traceable to the National Institute
of Standards and Technology (NIST), within the preceding two years.
c. Calibration of a particle accelerator
shall be performed by, or under the supervision of an authorized medical
physicist who meets the qualification requirements specified in
R9-7-711, and a copy of the
calibration report shall be maintained by the registrant for inspection by the
Department.
d. Calibration of the
therapy beam shall include, but not necessarily be limited to, all of the
following determinations:
i. Verification that
the equipment is operating within the design specifications concerning the
light localizer, the side light and back pointer alignment with the isocenter,
when applicable, variation in the axis of rotation for the table, gantry and
jaw system, and beam flatness and symmetry at specific depths;
ii. The exposure rate or dose rate in air or
at various depths of water for the range of field sizes used for each effective
energy, and for each treatment distance used for radiation therapy;
iii. The congruence between the radiation
field and the field defined by the localizing device;
iv. The uniformity of the radiation field and
its dependency upon the direction of the useful beam; and
v. The calibration determinations above shall
be provided in sufficient detail, to allow the absorbed dose to tissue in the
useful beam to be calculated to within plus or minus 5 percent.
e. Records of calibrations shall
be maintained for three years following the date the calibration was
performed.
f. A copy of the current
calibration report shall be available in the therapy facility for use by the
operator, and the report shall contain the following information:
i. The action taken by the authorized medical
physicist performing the calibration if it indicates a change has occurred
since the last calibration,
ii. A
listing of the persons informed of the change in calibration results,
and
iii. A statement as to the
effect the change in calibration has had on the therapy doses prior to the
current calibration finding.
C. Spot checks.
1. The spot check procedures shall be in
writing and shall have been developed by an authorized medical physicist
trained and experienced in performing calibrations.
2. The measurements taken during spot checks
shall demonstrate the degree of consistency of the operating characteristics
which can affect the radiation output of the system or the radiation dose
delivered to a patient during a therapy procedure.
3. The written spot check procedure shall
indicate the frequency at which tests or measurements are to be performed, not
to exceed monthly.
4. The spot
check procedure shall note conditions that require recalibration of the therapy
system before further human irradiation.
5. Records of spot checks shall be maintained
and available for inspection by the Department for three years following the
spot check measurements. Records of spot checks not performed by an authorized
medical physicist shall be signed by an authorized medical physicist within 15
days of the spot check.
D. Operating procedures.
1. Only the patient shall be in the treatment
room during irradiation.
2. If a
patient must be held in position during treatment only, mechanical supporting
or restraining devices shall be used for this purpose.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.